Pharmacokinetics and Modeling of Betamethasone Therapy in Threatened Preterm Birth
D
David Haas, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to evaluate the pharmacokinetic, pharmacodynamic, and pharmacogenetic parameters of betamethasone and determine the differences in responses and benefit in pregnancy.
Description
The purpose of this study is to evaluate the pharmacokinetic, pharmacodynamic, and pharmacogenetic parameters of betamethasone and determine the differences in responses and benefit in pregnancy.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
respiratory distress syndrome
-
Age: - 100 Years
-
Gender: All
Updated on
18 Apr 2024.
Study ID: 1604640151